Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccination

被引：41

作者：

Dillner, J.

Arbyn, M.

Dillner, L.

机构：

[1] Univ Hosp, Dept Clin Microbiol, WHO Global Reference Lab HPV Diag & Control, SE-20502 Malmo, Sweden

[2] Sci Inst Publ Hlth, Brussels, Belgium

[3] IARC, European Canc Network, Lyon, France

来源：

CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2007年 / 148卷 / 02期

关键词：

cancer prevention; surveillance; virus-like particles;

D O I：

10.1111/j.1365-2249.2007.03384.x

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Persistent infection with oncogenic human papillomavirus (HPV) is a necessary cause of cervical cancer. Moreover, HPV type 16 (and to a lesser degree HPV type 18) is linked with more rare cancers, namely cancer of the vulva, vagina, penis, anus, oropharynx and larynx. Effective prophylactic vaccines have been developed. In this review, we briefly address immunological aspects of HPV infection and the results of HPV vaccination trials. Internationally standardized monitoring and evaluation of prophylactic HPV vaccination programmes will be essential for arriving at the most (cost-)effective strategies for cancer control.

引用

收藏

页码：199 / 207

页数：9

相关论文

共 73 条

[1]

[Anonymous], 2004, GLOBOCAN 2002 CANC I

[2] Burden of cervical cancer in Europe: estimates for 2004 [J].

Arbyn, M. ;

Raifu, A. O. ;

Autier, P. ;

Ferlay, J. .

ANNALS OF ONCOLOGY, 2007, 18 (10) :1708-1715

[3] Review of current knowledge on HPV vaccination: An Appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening [J].

Arbyn, Marc ;

Dillner, Joakim .

JOURNAL OF CLINICAL VIROLOGY, 2007, 38 (03) :189-197

[4] Clinical applications of HPV testing: A summary of meta-analyses [J].

Arbyn, Marc ;

Sasieni, Peter ;

Meijer, Chris J. L. M. ;

Clavel, Christine ;

Koliopoulos, George ;

Dillner, Joakim .

VACCINE, 2006, 24 :78-89

[5]

BARNABAS RV, 2006, PLOS MED, V3, P1

[6] The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women [J].

Carter, JJ ;

Koutsky, LA ;

Wipf, GC ;

Christensen, ND ;

Lee, SK ;

Kuypers, J ;

Kiviat, N ;

Galloway, DA .

JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (05) :927-936

[7] Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection [J].

Carter, JJ ;

Koutsky, LA ;

Hughes, JP ;

Lee, SK ;

Kuypers, J ;

Kiviat, N ;

Galloway, DA .

JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (06) :1911-1919

[8] THE OPEN READING FRAME L2 OF COTTONTAIL RABBIT PAPILLOMAVIRUS CONTAINS ANTIBODY-INDUCING NEUTRALIZING EPITOPES [J].

CHRISTENSEN, ND ;

KREIDER, JW ;

KAN, NC ;

DIANGELO, SL .

VIROLOGY, 1991, 181 (02) :572-579

[9] Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types [J].

Christensen, ND ;

Cladel, NM ;

Reed, CA ;

Budgeon, LR ;

Embers, ME ;

Skulsky, DM ;

McClements, WL ;

Ludmerer, SW ;

Jansen, KU .

VIROLOGY, 2001, 291 (02) :324-334

[10] HPV type-distribution in women with and without cervical neoplastic diseases [J].

Clifford, Gary ;

Franceschi, Silvia ;

Diaz, Mireia ;

Munoz, Nubia ;

Villa, Luisa Lina .

VACCINE, 2006, 24 :26-34

← 1 2 3 4 5 6 7 8 →